399 related articles for article (PubMed ID: 11155014)
1. Hepatic adenoma associated with recombinant human growth hormone therapy in a patient with Turner's syndrome.
Espat J; Chamberlain RS; Sklar C; Blumgart LH
Dig Surg; 2000; 17(6):640-643. PubMed ID: 11155014
[TBL] [Abstract][Full Text] [Related]
2. [Growth hormone for Turner's syndrome].
Fishman A; Hochberg Z
Harefuah; 1991 Nov; 121(9):281-6. PubMed ID: 1800273
[TBL] [Abstract][Full Text] [Related]
3. Treatment of 80 patients with Turner's syndrome with recombinant human growth hormone (YM-17798) for one year: the results of a multicentric study in Japan. Committee for the Treatment of Turner's Syndrome.
Takano K; Shizume K; Hibi I
Endocrinol Jpn; 1989 Apr; 36(2):253-60. PubMed ID: 2673750
[TBL] [Abstract][Full Text] [Related]
4. Treatment of 94 patients with Turner's syndrome with recombinant human growth hormone (SM-9500) for two years--the results of a multicentric study in Japan. Committee for the Treatment of Turner's Syndrome.
Takano K; Shizume K; Hibi I
Endocrinol Jpn; 1989 Aug; 36(4):569-78. PubMed ID: 2684622
[TBL] [Abstract][Full Text] [Related]
5. Pituitary tumor and low gonadotropins in a patient with Turner's syndrome.
Mermilliod JA; Gatchair-Rose A; Svec F
J La State Med Soc; 1995 Dec; 147(12):540-3. PubMed ID: 8543891
[TBL] [Abstract][Full Text] [Related]
6. Growth hormone treatment in Turner's syndrome.
Takano K; Hizuka N; Shizume K
Acta Paediatr Scand Suppl; 1986; 325():58-63. PubMed ID: 3473892
[TBL] [Abstract][Full Text] [Related]
7. Body composition and physical fitness are major determinants of the growth hormone-insulin-like growth factor axis aberrations in adult Turner's syndrome, with important modulations by treatment with 17 beta-estradiol.
Gravholt CH; Naeraa RW; Fisker S; Christiansen JS
J Clin Endocrinol Metab; 1997 Aug; 82(8):2570-7. PubMed ID: 9253336
[TBL] [Abstract][Full Text] [Related]
8. Growth-promoting effect of growth hormone and low dose ethinyl estradiol in girls with Turner's syndrome.
Vanderschueren-Lodeweyckx M; Massa G; Maes M; Craen M; van Vliet G; Heinrichs C; Malvaux P
J Clin Endocrinol Metab; 1990 Jan; 70(1):122-6. PubMed ID: 2294126
[TBL] [Abstract][Full Text] [Related]
9. Glucose turnover and insulin clearance after growth hormone treatment in girls with Turner's syndrome.
Monti LD; Brambilla P; Caumo A; Magni F; Omati S; Nizzoli G; di Natale B; Galli-Kienle M; Cobelli C; Chiumello G; Pozza G
Metabolism; 1997 Dec; 46(12):1482-8. PubMed ID: 9439548
[TBL] [Abstract][Full Text] [Related]
10. Treatment of Turner's syndrome with methionyl human growth hormone for six months.
Takano K; Hizuka N; Shizume K
Acta Endocrinol (Copenh); 1986 May; 112(1):130-7. PubMed ID: 3521183
[TBL] [Abstract][Full Text] [Related]
11. Plasma growth hormone-binding protein activity, insulin-like growth factor I, and its binding protein levels in patients with Turner's syndrome: effect of short- and long-term recombinant human growth hormone administration.
Saggese G; Federico G; Cinquanta L
Pediatr Res; 1995 Jan; 37(1):106-11. PubMed ID: 7535419
[TBL] [Abstract][Full Text] [Related]
12. Treatment of 46 patients with Turner's syndrome with recombinant human growth hormone (YM-17798) for three years: a multicentre study.
Takano K; Shizume K; Hibi I
Acta Endocrinol (Copenh); 1992 Apr; 126(4):296-302. PubMed ID: 1595324
[TBL] [Abstract][Full Text] [Related]
13. Nephrogenic adenoma of the bladder in a girl with Turner's syndrome: an unusual association.
Kibar Y; Sümer F; Yildirim I; Gamsizkan M; Avci A; Dayanç M
Int J Urol; 2004 Sep; 11(9):795-7. PubMed ID: 15379949
[TBL] [Abstract][Full Text] [Related]
14. [Growth hormone (HGH) treatment of 7 cases of hyposomatotropism and 1 case of Turner's syndrome].
Peña J; Tresánchez J; Súarez M; Osorio C
Rev Clin Esp; 1972 Aug; 126(4):323-6. PubMed ID: 4638604
[No Abstract] [Full Text] [Related]
15. Effects of human growth hormone therapy on melanocytic naevi.
Bourguignon JP; Piérard GE; Ernould C; Heinrichs C; Craen M; Rochiccioli P; Arrese JE; Franchimont C
Lancet; 1993 Jun; 341(8859):1505-6. PubMed ID: 8099381
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone and craniofacial changes: preliminary data from studies in Turner's syndrome.
Simmons KE
Pediatrics; 1999 Oct; 104(4 Pt 2):1021-4. PubMed ID: 10506256
[TBL] [Abstract][Full Text] [Related]
17. Turner's syndrome: treatment of 203 patients with recombinant human growth hormone for one year. A multicentre study.
Takano K; Shizume K; Hibi I
Acta Endocrinol (Copenh); 1989 May; 120(5):559-68. PubMed ID: 2658450
[TBL] [Abstract][Full Text] [Related]
18. Growth hormone therapy in Turner's syndrome.
O'Shea D; Powell D
Ir Med J; 1992 Jun; 85(2):68-9. PubMed ID: 1628947
[TBL] [Abstract][Full Text] [Related]
19. Improved final height in girls with Turner's syndrome treated with growth hormone and oxandrolone.
Nilsson KO; Albertsson-Wikland K; Alm J; Aronson S; Gustafsson J; Hagenäs L; Häger A; Ivarsson SA; Karlberg J; Kriström B; Marcus C; Moell C; Ritzen M; Tuvemo T; Wattsgård C; Westgren U; Westphal O; Aman J
J Clin Endocrinol Metab; 1996 Feb; 81(2):635-40. PubMed ID: 8636281
[TBL] [Abstract][Full Text] [Related]
20. Effect of obesity on endogenous secretion of growth hormone in Turner's syndrome.
Lu PW; Cowell CT; Jimenez M; Simpson JM; Silink M
Arch Dis Child; 1991 Oct; 66(10):1184-90. PubMed ID: 1953000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
